web analytics
Analytical Method Development | Analytical Method Validation

Analytical Method Development

Analytical Method Development and Analytical Method Validation


Velesco is a contract drug manufacturing organization (CDMO) with experienced analytical staff specializing in analytical method development and validation for early to late stage pharmaceuticals and drug development processes. We also have experience with over the counter (OTC) and neutraceutical products.


Velesco Pharma can become involved in your analytical Chemistry, Manufacturing, and Controls (CMC) program at any stage. We develop drug substance and drug product analytical methods from scratch, improve and expand existing methods, and even troubleshoot and fix problematic analytical methods. Our analytical method validation will be appropriate for your drug development program and comply with ICH guidelines.


Our expert analytical chemists ensure that you will receive a robust, transferable, stability-indicating HPLC method that is tailored to your phase of development. Learn more about the importance of stability-indicating method and why it’s needed. 


Phase of drug development is very important for efficient analytical method development and analytical method validation. Our analytical approach means our methods are “fit for purpose”. Thus, methods for IND submission during phase I support are scientifically sound, but challenged in validation to a lesser extent than a phase III product methods.


An early phase clinical research project usually does not have extensive analytical data. There are usually small, unknown impurities and unknown degradation profiles. During early development, large batch-to-batch changes in these impurity profiles can occur. Velesco’s analytical scientists know how to run forced degradation studies and are familiar with the challenge of extracting and separating the new components, while minimizing changes to the method.


Velesco Pharma takes a practical approach to analytical method development, using solvents and columns that are affordable and readily available (unless a specialty item is necessary for the project).


Drug Product Release - Analytical Testing Laboratory


Our current Good Manufacturing Practice (cGMP) laboratory in Wixom, Michigan specializes in FDA GMP drug product release and stability studies.


Velesco Pharma can also perform routine analysis, from simple melting point determination or UV/VIS scan to GMP stability testing. Please complete the substance submission form for Velesco’s analytical testing laboratory services.


Our case studies for analytical method development challenges provide a brief taste of the value our analytical services can bring to your product development process.


  • Stability-indicating analytical methods
  • Drug substance
  • Drug product (tablets, capsules, syrups, etc.)
  • Forced degradation studies
  • Impurities
  • Chiral method development
  • Stability testing in support of first-in-human studies
  • Content uniformity method development, validation and testing
  • Dissolution method development, validation and testing
  • Blinded comparator agent testing
  • Analytical method troubleshooting
  • Analytical method optimization
  • Extractables, leachables Reference GMP regulations and standards
  • Cleaning verification guidelines and method development, validation
  • Technology transfer methods


LORIE LANE 3 resize 15 cleanroom


News and Events

Pace® Life Sciences Acquires Velesco Pharmaceutical Services, Expanding Capabilities in Drug Development Services

Read the Press Release!

Dave Barnes, Ph.D. CEO/CSO is a featured speaker for the webinar Topical Formulation: Selection of Excipients and Better Process Understanding for Success in Commercial Manufacturing. Webinar recording available now.

View Recording!

Newly Acquired DEA Analytical Laboratory License. We are licensed to use schedules 2, 2N, 3, 3N, 4, and 5.

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Gerry Cox, Founder and Chief Operating Officer at Velesco Pharmaceutical Services.

Roundtable: M&A trends in CDMO - Molecule to Market

New Velesco Pharma clinical manufacturing facility begins operations.

Read the press release here.

Lisa Crandall, MS, and Peter Angus, PhD, spoke with Pharmaceutical Technology about the best practices in stability testing.

Read the interview here.

Velesco has expanded our analytical facilities in a new Wixom, Michigan location with the help of the Bank of Ann Arbor Technology Industry Group.

Read the press release here.

CEO Dave Barnes has been published in a new Pharmoutsourcing article on Clinical Trial Materials and Manufacturing!

1 new job postings! Careers

Velesco's work published

Formulation Development & Manufacturing:
Using a Single Provider Reduces Costs & Risk
Read it here.

Follow Velesco

LinkedIn IN Icon 25px Google+ Follow VelescoPharma on Twitter FB FindUsOnFacebook 100